Home Page Services Selected Clients Testimonials Our Team Capital Markets IPO Boot Camp Contact Us
Welcome


Emergent BioSolutions Inc.

2273 Research Boulevard, Suite 400
Rockville, MD 20850
301-795-1800

Visit Website

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the body's immune system to prevent or treat disease. Emergent's marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax disease. Emergent's product pipeline targets infectious diseases and includes programs focused on anthrax, tuberculosis, typhoid, flu and chlamydia.

Company Management

  • Fuad El-Hibri, CEO
  • R. Don Elsey, CFO
  • R. Don Elsey, Investor Relations Contact

Westwicke Contacts

  • Bob East

Request a Meeting